The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling
Open accessAbstract
Many tumors contain heterogeneous populations of cells, only some of which exhibit increased tumorigenicity and resistance to anticancer therapies. Evidence suggests that these aggressive cancer cells, often termed “cancer stem cells” or “cancer stem-like cells” (CSCs), rely upon developmental signaling pathways that are important for survival and expansion of normal stem cells. Here we report that, in analogy to embryonic mammary epithelial biology, estrogen signaling expands the pool of functional breast CSCs through a paracrine FGF/FGFR/Tbx3 signaling pathway. Estrogen or FGF9 pretreatment induced CSC properties of breast cancer cell lines and freshly isolated breast cancer cells, whereas cotreatment of cells with tamoxifen or a small molecule inhibitor of FGFR signaling was sufficient to prevent the estrogen-induced expansion of CSCs. Furthermore, reduction of FGFR or Tbx3 gene expression was able to abrogate tumorsphere formation, whereas ectopic Tbx3 expression increased tumor seeding potential by 100-fold. These findings demonstrate that breast CSCs are stimulated by estrogen through a signaling pathway that similarly controls normal mammary epithelial stem cell biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,612
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H. M., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,051
Ben-Porath, I., Thomson, M. W., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,523
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Self-citationlet-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.054 · Cited by 1,910
Ponti, D., Costa, A., Zaffaroni, N., Pratesi, G., Petrangolini, G., Coradini, D., Pilotti, S., Pierotti, M. A., & Daidone, M. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0626 · Cited by 1,723
Creighton, C. J., Li, X., Landis, M., Dixon, J. M., Neumeister, V. M., Sjolund, A., Rimm, D. L., Wong, H., Rodriguez, A., Herschkowitz, J. I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905718106 · Cited by 1,412
Fillmore, C. M., & Kuperwasser, C. (2008) · Breast Cancer Research · doi:10.1186/bcr1982 · Cited by 1,033
Self-citationControl of mammary stem cell function by steroid hormone signalling
Asselin-Labat, M.-L., Vaillant, F., Sheridan, J. M., Pal, B., Wu, D., Simpson, E. R., Yasuda, H., Smyth, G. K., Martin, T. J., Lindeman, G. J., et al. (2010) · Nature · doi:10.1038/nature09027 · Cited by 693 · cited 1×
“Similar observations have been made in the normal mouse mammary gland, in which epithelial stem cell function is controlled in part through RANKL andWnt4, which are secreted in response to both estrogen and progesterone (24, 25).”
BackgroundProgesterone induces adult mammary stem cell expansion
Joshi, P. A., Jackson, H. W., Beristain, A. G., Di Grappa, M. A., Mote, P. A., Clarke, C. L., Stingl, J., Waterhouse, P. D., & Khokha, R. (2010) · Nature · doi:10.1038/nature09091 · Cited by 689
Mallepell, S., Krust, A., Chambon, P., & Brisken, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510974103 · Cited by 432
DiMeo, T. A., Anderson, K., Phadke, P., Feng, C., Perou, C. M., Naber, S., & Kuperwasser, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4135 · Cited by 414
Self-citationSomervaille, T. C. P., Matheny, C. J., Spencer, G. J., Iwasaki, M., Rinn, J. L., Witten, D. M., Chang, H. Y., Shurtleff, S. A., Downing, J. R., & Cleary, M. L. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2008.11.015 · Cited by 357
Hiscox, S., Jiang, W. G., Obermeier, K., Taylor, K., Morgan, L., Burmi, R., Barrow, D., & Nicholson, R. I. (2006) · International Journal of Cancer · doi:10.1002/ijc.21355 · Cited by 260
Cooperation of signalling pathways in embryonic mammary gland development
Robinson, G. W. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2227 · Cited by 194
Intrauterine environments and breast cancer risk: meta-analysis and systematic review
Park, S. K., Kang, D., McGlynn, K. A., García‐Closas, M., Kim, Y.-J., Yoo, K. Y., & Brinton, L. A. (2008) · Breast Cancer Research · doi:10.1186/bcr1850 · Cited by 144
McLeskey, S. W., Kurebayashi, J., Honig, S. F., Zwiebel, J. A., Lippman, M. E., Dickson, R. B., & Kern, F. G. (1993) · PubMed · Cited by 126
Eblaghie, M. C., Song, S., Kim, J., Akita, K., Tickle, C., & Jung, H. (2004) · Journal of Anatomy · doi:10.1111/j.0021-8782.2004.00309.x · Cited by 121
Brisken, C., & Duss, S. (2007) · Stem Cell Reviews and Reports · doi:10.1007/s12015-007-0019-1 · Cited by 115
TBX3 Is Overexpressed in Breast Cancer and Represses p14ARF by Interacting with Histone Deacetylases
Yarosh, W., Barrientos, T., Esmailpour, T., Lin, L., Carpenter, P. M., Osann, K., Anton-Culver, H., & Huang, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5012 · Cited by 105
Cui, Y., Parra, I., Zhang, M., Hilsenbeck, S. G., Tsimelzon, A. I., Furukawa, T., Horii, A., Zhang, Z., Nicholson, R. I., & Fuqua, S. A. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3243 · Cited by 101
The Role of Tbx2 and Tbx3 in Mammary Development and Tumorigenesis
Rowley, M., Grothey, E., & Couch, F. J. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000037156.64331.3f · Cited by 97
Coleman-Krnacik, S., & Rosen, J. M. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.2.8170478 · Cited by 95
Wing, L. C., Chuang, P.-C., Wu, M., Chen, H., & Tsai, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030597 · Cited by 70
Hassan, K. A., Chen, G., Kalemkerian, G. P., Wicha, M. S., & Beer, D. G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1105 · Cited by 64
Noël, A., Simon, N., Raus, J., & Foidart, J. M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90501-9 · Cited by 49
A Crucial Role for Fibroblast Growth Factor Signaling in Embryonic Mammary Gland Development
Dillon, C., Spencer‐Dene, B., & Dickson, C. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000037163.56461.1e · Cited by 43
Cited by
The landscape of cancer genes and mutational processes in breast cancer
The Oslo Breast Cancer Consortium (OSBREAC), Stephens, P. J., Tarpey, P. S., Davies, H., Van Loo, P., Greenman, C., Wedge, D. C., Nik-Zainal, S., Martin, S., Varela, I., et al. (2012) · Nature · doi:10.1038/nature11017 · Cited by 1,698
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Gupta, P. B., Fillmore, C. M., Jiang, G., Shapira, S. D., Tao, K., Kuperwasser, C., & Lander, E. S. (2011) · Cell · doi:10.1016/j.cell.2011.07.026 · Cited by 1,475
Self-citationWhole-genome analysis informs breast cancer response to aromatase inhibition
Ellis, M. J., Ding, L., Shen, D., Luo, J., Suman, V. J., Wallis, J. W., Van Tine, B. A., Hoog, J., Goiffon, R. J., Goldstein, T. C., et al. (2012) · Nature · doi:10.1038/nature11143 · Cited by 1,023
Advances and challenges in targeting FGFR signalling in cancer
Babina, I. S., & Turner, N. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.8 · Cited by 799
Breast cancer stem cells, cytokine networks, and the tumor microenvironment
Korkaya, H., Liu, S., & Wicha, M. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57099 · Cited by 616
Metadata
- Authors
- Fillmore, C. M., Gupta, P. B., Rudnick, J. A., Caballero, S., Keller, P. J., Lander, E. S., & Kuperwasser, C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-11-22
- Volume
- 107
- Issue
- 50
- Pages
- 21737-21742
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2100502993
- Cited by
- 283
- References
- 29
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.